Biosantara, UAB - financials and debts

Company age: 16 y. 6 mo.

Update

Biosantara - Company finances

  • The company is late in submitting financial data for the previous financial year.
  • Latest financial data up to 2024-12-31.
EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
Financial data
Sales revenue 2,000 0 - 3,600 - - -
Profit before tax 4,116,323 7,326,233 6,040,352 8,200,131 13,460,408 36,639,222 20,931,558
Net profit 4,116,323 7,320,384 6,040,352 8,163,356 13,401,294 36,517,212 20,771,851
Equity 4,119,509 7,323,570 6,043,538 8,166,542 13,404,480 36,520,398 20,775,037
Liabilities 5,937,804 9,559,891 16,556,808 22,271,351 26,560,066 36,935,911 71,035,514
Non-current assets 1,446,437 3,739,125 3,884,374 12,046,635 13,061,686 30,186,964 15,737,401
Current assets 8,613,376 13,147,036 18,718,672 18,394,758 26,908,660 43,275,345 76,052,371
Total assets 10,059,813 16,886,161 22,603,046 30,441,393 39,970,346 73,462,309 91,789,772
Taxes paid
STI taxes - - - - - 547,816 525,692
Financial indicators
Revenue change y/y -50.0% - - - - - -
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 40.9% 43.4% 26.7% 26.8% 33.5% 49.7% 22.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 99.9% 100.0% 99.9% 100.0% 100.0% 100.0% 100.0%
Profit margin Net profit margin. Shows the overall profitability of the company. 205816.2% - - 226759.9% - - -
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 205816.2% - - 227781.4% - - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.4 1.3 2.7 2.7 2.0 1.0 3.4
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 2,000 - - 3,600 - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

Consolidated Biosantara finance

EUR
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
Financial data
Sales revenue 123,919,188 93,045,600 74,035,286
Profit before tax 60,514,276 51,592,892 47,622,741
Net profit 46,026,303 39,283,785 36,523,545
Equity 110,204,975 130,417,760 135,398,862
Liabilities 68,907,631 68,866,243 98,173,466
Non-current assets 97,757,216 85,414,210 99,419,372
Current assets 93,102,659 124,752,755 144,475,396
Total assets 190,859,875 210,166,965 243,894,768

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Biosantara - Social security debts

From To Debt, €
2024-01-23 2024-02-07 0.01
2023-12-18 2023-12-28 2.54
2021-09-16 2021-10-06 0.01

Biosantara - VMI tax arrears

From To Overdue, €
2025-04-20 2025-05-13 2.24
2025-04-19 2025-04-19 0.98
2024-12-19 2024-12-19 16.48

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.